Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
David C. Fajgenbaum(University of Pennsylvania), Éric Oksenhendler(Université Paris Cité), Simone Ferrero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Raj Jayanthan(Baylor College of Medicine), Steve Schey(King's College London), Megan S. Lim(Memorial Sloan Kettering Cancer Center), Heather A. Leitch(University of British Columbia), Alexander Fosså(Oslo University Hospital), Raymond Wong(Chinese University of Hong Kong), Yasuharu Sato(Okayama University), Amy Chadburn(Cornell University), Gordan Srkalović(Regional Cancer Center), Mary Jo Lechowicz(Emory University), Sunita D. Nasta(University of Pennsylvania), Naveen Pemmaraju(The University of Texas MD Anderson Cancer Center), Adam Bagg(University of Pennsylvania), Frits van Rhee(Winthrop Rockefeller Foundation), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Sudipto Mukherjee(Cleveland Clinic), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Aaron M. Goodman(University of California San Diego), Angela Dispenzieri(Mayo Clinic), David Wu(University of Washington)
Cited by 32
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k